Trials / Sponsors / EGEN, Inc.
EGEN, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combi Colorectal Cancer | Phase 1 / Phase 2 | 2011-06-01 |
| Completed | Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovar Ovarian Neoplasms | Phase 1 | 2007-04-01 |
| Terminated | Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer Ovarian Neoplasms | Phase 1 | 2005-08-01 |